1.62 Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M

News


<< back

Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Date: 2024-05-16 [news.yahoo.com]

READ THE FULL NEWS >>
×